Related Experiment Video
Updated: Dec 27, 2025

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG
Sonja Hochmeister1, Thomas Gattringer1, Martin Asslaber2
1Department of Neurology, Medical University Graz, Graz, Austria.
Abstract:
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syndromes such as optic neuritis, myelitis, and brainstem encephalitis. Most often, the presence of MOG-Abs is associated with a more benign clinical course and a good response to steroids. Here, we present a case report of a previously healthy 52-year-old female patient with fulminant demyelinating encephalitis, leading to death within a week after the first presenting symptoms from a massive brain edema irresponsive to high-dose intravenous steroids as well as osmotic therapy. The final diagnosis was only made postmortem after serum anti-MOG-Abs results were available. Histopathological analysis of the brain revealed extensive, predominantly cortical demyelinating lesions in the frontal, temporal, and parietal lobes with intracortical, leukocortical, and subpial plaques, associated with pronounced perivenous deposition of activated complement complex as well as features of acute MS characterized by destructive lesions.
Insights
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies typically indicate a milder disease course. However, this case report details a fatal, fulminant demyelinating encephalitis caused by MOG antibodies, highlighting a rare, aggressive presentation.
Area of Science:
- Neuroimmunology
- Neuropathology
Background:
- Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies are linked to demyelinating diseases like ADEM and NMOSD.
- MOG-antibody-associated diseases often present with a favorable prognosis and steroid responsiveness.
More Related Videos
05:55Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013